Verve Therapeutics (VERV) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

VERV Verve Therapeutics

Watchlist

5.610
-0.170-2.94%

Close Nov 29 13:00 ET

5.630
+0.020+0.36%

Post 17:01 ET

474.96MMarket Cap-2280P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswireNov 29 16:05 ET
Express News | Verve Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
ReutersNov 29 16:05 ET
Express News | Bvf Partners LP Reports 8.2% Passive Stake in Verve Therapeutics Inc as of Nov 11 - SEC Filing
ReutersNov 18 17:31 ET
ARKK's Holdings Ranked by SA Quant Grades
Seeking AlphaNov 12 14:21 ET
CRISPR, Beam, Other Gene Editing Names up Significantly
Seeking AlphaNov 11 13:15 ET
RBC Capital Maintains Verve Therapeutics(VERV.US) With Buy Rating, Cuts Target Price to $17
Moomoo NewsNov 6 13:32 ET · Ratings

Comments

$Verve Therapeutics (VERV.US)$ hmm

$Verve Therapeutics (VERV.US)$ annnnnnnndd its gone

$Verve Therapeutics (VERV.US)$ premarket looking good

$Verve Therapeutics (VERV.US)$ 👀

1

MARKET-TEST-DUMMY

$Verve Therapeutics (VERV.US)$

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data